Med-tech firms raising money in public or private financings, including: Adapthealth, Axogen, Biodirection, Genome Medical, Nanodiagnostics, Rewalk Robotics, Tela Bio.

New hires and promotions in the med-tech industry, including: Biosig Technologies, Edap Tms, Hallura, Mentice, Sharps Compliance.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Bavarian, Blueprint, EMD, Golden, Hangzhou Yuyuan, Isa, Janssen, Medicinova, Mezzion, Pfizer, Revive, Rhythm, Scpharmaceuticals, Sun, TC, Obseva, Ultragenyx, Y-mabs.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Advanced Biodesign, Aligos, Avadel, Binx Health, Bioinvent, Boehringer Ingelheim, Canagen, Celsius, Crestone, Dr. Reddy’s, Eisai, Emollivet, Epicentrx, Exela, Fujifilm, Foresight, G1, Genix, Ginkgo Bioworks, Leo, Liminal, Lipidor, Myneo, Pfizer, Prometic, Quralis, Repurpose.AI, Revolution Medicines, Sciclone, Sherlock Biosciences, Sumitomo Dainippon, Therapix, Thinkcyte, Van Heron Labs.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Akero, Anavex, Biondvax, Biontech, Context, Corcept, Daiichi, Durect, Eyenovia, Ipsen, Matinas, Oncolys, Pfizer, Polypid, Revance, Timber, Vasopharm.

Biopharmas raising money in public or private financings, including: Acceleron, Akari, Akouos, Amylyx, Chiasma, Crispr Therapeutics, DFP Healthcare Acquisitions, IMV, Orphazyme, Painreform, Panacea Acquisition, Tela Bio.

New hires and promotions in the biopharma industry, including: 4Bio, Akari, Arcturus, Beigene, Cellectar, Codiak, Egenesis, Khondrion, Moderna, Scenic, Sotio, Trevi, Xoma, Zentalis.

Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: Celltex, Citius, Cytocom, Daiichi Sankyo, Eisai, EMD Serono, Fulcrum, Gilead Sciences, Immunovative, Incyte, Mayne, Merz, Mirror Biologics, Neurorx, Novartis, Novo Nordisk, Rakuten Medical, Relief, Renibus, Roche, Samsung Bioepis, Sinovac, Teijin.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Algernon, Cytodyn, Fibrogen, Immutep, Montreal Heart Institute, Noxopharm, Revimmune.

Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief, including: Alteogen, Altimmune, Aptevo, Avita Medical, Berlin Cures, Biosig, Cadila, Cancer Research UK, CARB-X, Catalent, Daiichi Sankyo, Eli Lilly, Emergent, Entos, Everinsight, Gilead Sciences, Ignova, Immuneering, Immunomic, Immunoprecise Antibodies, International Business Machines, Inxmed, JS Innomed, Lion TCR, Mateon, Melior, Moderna, Novartis, Oncology Venture, Otsuka, Palatin, Peel, Pfizer, Pharmabcine, Renibus, Repertoire Immune Medicines, Replicate, Schrödinger, Taiho, Takeda, Thermo Fisher, Vaxart, Vistagen, Vitrac, Wuxi.